Supplementary materialS Supplementary material and methods of table 10
The synthetic GSTM3 gene was designed according to S. cerevisiae codon usage with the Synthetic Gene Designer program (Wu G et al. 2005) . The 60 to 80 nucleotide oligos were dissolved at a final concentration of 25 μM, and melting temperature (Tm) was adjusted to approximately 60° C (Supplementary Table 10) . Overlapping results for oligo-sets following the two-step PCR method were used for the construction of synthetic gene (Dillon PJ. & CA Rosen. 1990 ). AccuPrime Pfx DNA polymerase (Invitrogen) was added to the first round of PCR, using an annealing temperature of 60° C, and sequential elongation times of 30 seconds up to 2 min were used for 3-5 cycles. A total of 2 µL of the products was employed as a template for the second PCR using primers with restriction sites flanking the full-length product. The PCR products were cut with the HindIII and BamHI enzymes (Fermentas) and inserted into the pYES2 plasmid. The resulting expression plasmids were replicated in E. coli DH5α and then in S. cerevisiae Σ1278B (MATα ura3) strain. The cells were routinely grown in YEPD medium, and yeast transformation with the expression plasmids was performed as described in the user manual (version K) of the pYES2 kit (Invitrogen). The transformed yeast cells were selected on minimal plates containing 0.67% YND (Difco, BD) with amino acids (Leu-free), 2% dextrose and 2% agar. The induction of recombinant protein was performed in 150mL flasks with 50 mL of induction medium (0.67% YNB with amino acids (Leu-free), 2% L-galactose and 2% raffinose). We inoculated the cultures with approximately 5 × 105 yeast cells/mL in each flask. After 72 hours of incubation at 30° C with constant shaking (200 rpm), the cells were collected, flash-frozen and stored at -80° C. The induced yeast cells were washed with 50 mL ddH2O three times and resuspended in 1 mL of 50 mM Kpi buffer (7.0 pH), with 5% glycerol and a protease inhibitor cocktail (Complete tablet, Roche).
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1. Dillon PJ, Rosen CA. A rapid method for the construction of synthetic genes using the polymerase chain reaction. Biotechniques. 1990; 9:298, 300. Proteins with different expression between HeLa and SiHa tumors. Spot normalization was employed using total density in gel image, to ensure the independence of the data from experimental variations between gels. Student's t-test was performed to assess the significance of differences between differentially expressed proteins.
Supplementary Figure 2:
Workflows for obtaining in vivo or ex vivo secreted proteins. Cell lines were cultured in advanced RPMI 1640 (Gibco, Invitrogen) serum-free medium until 70-80 % of confluence was reached in 500 cm 2 Triple Flasks (Nunc Clon). The medium was removed and cells were rinsed three times with 500-600 mL of sterile physiological solution (NaCl 0.9% (w/v)). After washing, fresh RPMI 1640 phenol red-free medium was added (Gibco, Invitrogen) and cells were incubated for 20 hours. Later, the medium was removed and centrifuged at 1,500 g for 5 min. The supernatant was passed through a 0.22 μm pore size PVDF membrane (Millex, Millipore) and stored at -70° C until further use. For secreted proteins from HeLa and SiHa tumors, female Nu/Nu mice (age 4-6 weeks) were inoculated with 107 cells. After 30, 45 and 50 days' post-inoculation, tumors were collected (3 different replicates were used) and washed 3 times with 50 mL of physiological solution to then be incubated 20 hours, with phenol red-free and serum-free RMPI. As we did for we in vitro experiments, the medium was removed and centrifuged at 1,500 g for 5 min. The supernatant was passed through a 0.22 μm pore size membrane PVDF (Millex, Millipore) and stored at -70° C until further use. Subsequently, in vitro and ex vivo secreted proteins were lyophilized and resuspended in 1 mL ultrapure water. Protein isolation was performed through phenol extraction as described in Methods.
Supplementary figure 3: yeast plasmids construction, transformation, and recombinant protein expression.
(a) Recombinant human protein GSTM3 with a His-tag was expressed in Saccharomyces cerevisiae. The samples were separated on 12% SDS-PAGE. Line 1: Markers, Line 2: ScGSTM3 lysate (GSTM3 N-6x His-Tag on Saccharomyces cerevisiae), Line 3 and 4: purification washes, Line 5 and 6: purified ScGSTM3 with 300 mM of Imidazole. ScGSTM3 was identified through peptide mass fingerprinting using the Mascot program (Matrix Science). (b) After capturing the recombinant GSTM3, it was incubated with a protein extract of HeLa cells (HPV18 positive) at 4° C overnight. GSTM3 6xhis-tag protein interactions were analyzed. Line 1: Markers, Line 2 and 3: ScGSTM3 flow throughput, Line 4: HeLa proteins that do not interact with ScGSTM3, Line 5: HeLa proteins interaction with ScGSTM3. HPV18 E7 protein co-eluted with ScGSTM3 and could be identified using western blot (20 µg of protein and a specific antibody). (c) Recombinant protein of HPV18 E7 with a His-tag expression in HeLa cell line. The samples were separated on 15% SDS-PAGE. Line 1: Markers, Line 2: HeLa flow throughput, Line 3 and 4: purification washes, Line 5 and 6: purified HeLaE718 with 300mM of Imidazole. HeLaE718 was identified by western blot with specific antibody his-tag. (D). After capturing the recombinant HPV18 E7 6x his-tag with Nickel beads, it was incubated to 4° C overnight with HeLa proteins. Line 1: Markers, Line 2 and 3: purification washes, Line 4: HeLa proteins that interact with HE718. GSTM3 protein co-elute with HPV18 E7 protein could be identified using western blot and peptide mass fingerprinting as well as LC-MS/MS (20µg of protein and a specific antibody).
Supplementary figure 4:
(a) MDA-MB-231 negative to HPV18 (1) and GSTs (GSTM3 and GSTP1). Electrophoresis gel 1% agarose with PCR products of L1 gene of HPV and β-globin as a control, and western blot of GSTM3 and GSTP1 (b) GSTM3 and GSTP1 protein expression in MDA (breast cancer) and COLO (colon cancer) tumors. A negative expression in GSTP1 protein in MDA cell line had no significant changes in tumor growth. COLO cell line showed a decrease in GSTP1 protein expression with morpholino treatment and a decrement of tumor growth of 47.7% with M-GSTM3 treatment. 
